The fire at Long Island’s Happy Cat Sanctuary that killed owner Chris Arsenault and over 160 animals has been deemed not ...

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics.” So the team grew the bacteria found in ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics for the condition in nearly 30 years. Blujepa ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant ...

The need to develop antibiotics to combat growing antimicrobial resistance, combined with the difficulty of their discovery and the lack of financial support for their development, is a major ...

He just captivates people. And I think it’s why he is where he is.” Triple H on Donald Trump: “Trump’s ability, like him or hate him the way he does it… he’s charismatic in so many ...